Detalles de la búsqueda
1.
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
N Engl J Med
; 378(26): 2475-2485, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29782224
2.
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
N Engl J Med
; 378(26): 2486-2496, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29782217
3.
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
Acta Derm Venereol
; 101(11): adv00585, 2021 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618162
4.
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
Allergy
; 75(1): 148-157, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31306495
5.
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
Br J Dermatol
; 190(6): 917-919, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593196
6.
Development and validation of a caregiver-reported Numeric Rating Scale for measuring worst scratch/itch in patients aged 6 months to younger than 6 years with atopic dermatitis.
J Am Acad Dermatol
; 90(2): 382-385, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778662
7.
Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
Dig Dis Sci
; 64(1): 60-67, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30311154
8.
Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.
Dig Dis Sci
; 64(5): 1142-1149, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659472
9.
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Ophthalmology
; 123(3): 655-62, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712559
10.
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use.
Acta Derm Venereol
; 101(7): adv00504, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043020
11.
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease.
Clin Gastroenterol Hepatol
; 13(2): 316-21, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038374
12.
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
Gastroenterology
; 146(1): 110-118.e3, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24067881
13.
Adalimumab induces deep remission in patients with Crohn's disease.
Clin Gastroenterol Hepatol
; 12(3): 414-22.e5, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23856361
14.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Dermatol Ther (Heidelb)
; 13(9): 2107-2120, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552431
15.
Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease.
Pharmacy (Basel)
; 10(4)2022 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35893725
16.
Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years.
J Patient Rep Outcomes
; 6(1): 55, 2022 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633412
17.
Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study.
Patient Prefer Adherence
; 16: 2649-2661, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36176349
18.
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 12(12): 2839-2850, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269504
19.
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
Respir Med
; 191: 105991, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090688
20.
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment.
Dermatol Ther (Heidelb)
; 12(1): 195-202, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897582